ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
2.000
-0.050 (-2.44%)
Aug 28, 2026, 4:00 PM EDT - Market closed

ALX Oncology Holdings Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
22.6916.3717.5722.4148.82363.67
Short-Term Investments
115.5428.42110.19160.33217.39-
Cash & Short-Term Investments
138.2344.79127.76182.74266.21363.67
Cash Growth
74.28%-64.94%-30.09%-31.36%-26.80%-16.25%
Other Receivables
1.170.30.891--
Receivables
1.170.30.891--
Prepaid Expenses
3.525.625.684.494.763.35
Other Current Assets
0.540.020.030.44--
Total Current Assets
143.4650.73134.35188.66270.97367.02
Property, Plant & Equipment
1.443.879.6310.849.813.47
Long-Term Investments
15.153.493.5235.4116.7-
Other Long-Term Assets
0.780.950.277.649.019.69
Total Assets
160.8259.05147.78242.55306.49380.18

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
3.024.914.58.598.073.76
Accrued Expenses
8.8910.559.2615.4410.799.6
Current Portion of Long-Term Debt
-5.220.44---
Current Portion of Leases
1.251.86---0.74
Other Current Liabilities
1.622.014.311.979.461.19
Total Current Liabilities
14.7824.5518.53628.3315.3
Long-Term Debt
9.714.539.479.649.39-
Long-Term Leases
0.093.16----
Other Long-Term Liabilities
0.070.826.197.25.311.84
Total Liabilities
24.6333.0734.1652.8443.0317.13

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.140.050.050.050.040.04
Additional Paid-In Capital
894.99748.72734.41675.68589.74564.99
Retained Earnings
-758.72-722.82-621.12-486.27-325.47-201.99
Comprehensive Income & Other
-0.220.030.280.26-0.85-
Total Common Equity
136.1925.98113.62189.71263.46363.05
Shareholders' Equity
136.1925.98113.62189.71263.46363.05
Total Liabilities & Equity
160.8259.05147.78242.55306.49380.18

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
11.0414.779.99.649.390.74
Net Cash (Debt)
127.1930.02117.85173.1256.82362.93
Net Cash Growth
101.47%-74.53%-31.91%-32.60%-29.24%-16.42%
Net Cash Per Share
1.470.562.264.036.319.00
Filing Date Shares Outstanding
138.28131.6153.3850.1540.8640.63
Total Common Shares Outstanding
138.2254.3953.0549.9540.8640.59
Working Capital
128.6826.17115.85152.66242.64351.72
Book Value Per Share
0.990.482.143.806.458.94
Tangible Book Value
136.1925.98113.62189.71263.46363.05
Tangible Book Value Per Share
0.990.482.143.806.458.94
Machinery
0.882.472.472.311.930.73
Leasehold Improvements
0.220.712.512.512.360.23
SEC Filings: 10-K · 10-Q